Wilm’s Tumor Market Estimated to Flourish at by 2024

Wilm’s Tumor Market Estimated to Experience a Hike in
Growth by 2024
Wilm’s tumor also called Nephroblastoma is a type of cancer that starts in the
kidneys and is most common type of kidney cancer in children. The ratio of
Wilm’s tumor is about 9 of 10 kidney cancers in children. Tumors which affects
only one kidney and have only one tumor are unilateral. Around 5-10% of
children with Wilm’s tumors have more than one tumor in same kidney. About
5% of children with Wilm’s tumors have tumors in both kidneys which means
they have bilateral disease. Wilm’s tumors often become large, averagely
newly found Wilm’s tumor is larger than the kidney in which it is started.
Common symptoms present in children are fever and bleeding during urination,
abdominal swelling and abdominal pain. In present scenario, survival rate of
children suffering from Wilm’s tumor is approximately 80% to 90%. Average
age at diagnosis is about 3-4 years and is rare as children grow older and is
uncommon after age 6.
Request to Browse Full Table of Content, figure and Tables @
Technological advancement owing to rise in enhanced diagnostics and
treatment therapies, increasing number of births per year are some of the
factors which will drive the Wilm’s tumor market. In addition macro-economic
factors like increasing expenditure on research and development to bring out
novel therapies for Wilm’s tumor will drive this market in forecast period. Due
to the high cost of treatment of therapies this can hamper the overall growth of
the Wilm’s tumor market.
The incidence of Wilm’s tumor in children below 15 years is 7.1 cases per 1
million children. It is observed that Wilm’s tumor is slightly more in girls than
boys and is especially in Africa and U.S. Factors such as increasing demand for
diagnostic solutions and treatment therapies for Wilms tumor, Wilm’s tumor
market is expected to have tremendous growth during the forecast period
Request Sample Report @
On the basis of region presence, abdominal aortic aneurysm treatment market
is segmented into five key regions: North America, Latin America, Europe, Asia
Pacific, and Middle East & Africa.
Analyzing the present scenario North America dominates the global market for
Wilms tumor followed by Europe due to the high incidence rate of Wilms tumor.
According to the American Society of Cancer in 2015 about 500 new cases of
Wilms tumor are diagnosed in the U.S. The Wilms tumor is relatively more in
African countries while comparatively less in East Asia.
Many companies have their presence in this market while some of them have
their drugs in the pipeline for clinical trials. Some of the key player in Wilm’s
Tumor Market are Merck & Co.Inc, MediLexicon International Ltd, Bristol-Myers
Read Report Overview @
Persistence Market Research (PMR) is a third-platform research firm. Our
research model is a unique collaboration of data analytics and market research
methodology to help businesses achieve optimal performance. To support
companies in overcoming complex business challenges, we follow a multidisciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and
customer experience analytics, we deliver business intelligence for
organizations of all sizes.
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com